vanilmandelic acid has been researched along with Tourette Syndrome in 1 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
Tourette Syndrome: A neuropsychological disorder related to alterations in DOPAMINE metabolism and neurotransmission involving frontal-subcortical neuronal circuits. Both multiple motor and one or more vocal tics need to be present with TICS occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or another medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. (From DSM-IV, 1994; Neurol Clin 1997 May;15(2):357-79)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Messiha, FS | 1 |
Knopp, W | 1 |
Vanecko, S | 1 |
O'Brien, V | 1 |
Corson, SA | 1 |
1 other study available for vanilmandelic acid and Tourette Syndrome
Article | Year |
---|---|
Haloperidol therapy in Tourette's syndrome: neurophysiological, biochemical and behavioral correlates.
Topics: Adolescent; Behavior; Catecholamines; Dopamine; Haloperidol; Humans; Male; Norepinephrine; Phenylace | 1971 |